Mouna Ibourk

Mouna Ibourk is an experienced scientist specializing in assay development and protein biochemistry with a career spanning over a decade. Currently serving as a Scientist in Assay Development at Pfizer since September 2018, Mouna Ibourk designs and implements ligand binding assays for compound concentration and anti-drug antibody detection. Previous roles include QC Team Lead and Scientist at Vericel Corporation, as well as a Principal Development Associate and Development Associate at Boston Children's Hospital. Mouna Ibourk has also held positions as a Scientist II at Permeon Biologics and a Senior Research Assistant at Aileron Therapeutics, where notable contributions included establishing a protein expression and purification system. Educational credentials include a Master's degree in Biology from Northeastern University and a Bachelor's degree in Biology from the University of Southern Maine.